Catalyst Watch: China Trade Talks, Walmart Earnings, and Take-Two on the GTA Hot Seat
Myriad Genetics Price Target Cut to $6.00/Share From $22.00 by Wells Fargo
A Quick Look at Today's Ratings for Myriad Genetics(MYGN.US), With a Forecast Between $10 to $18
Earnings Release: Here's Why Analysts Cut Their Myriad Genetics, Inc. (NASDAQ:MYGN) Price Target To US$10.54
Wolfe Research Downgrades Myriad Genetics to Peer Perform From Outperform
Express News | Myriad Genetics, Inc. : Wells Fargo Cuts Target Price to $6 From $22
Hold Rating Maintained for Myriad Genetics Amid Revenue Cuts and Strategic Uncertainty
Myriad Genetics Faces Challenges Amid Prenatal Testing Growth
New Analyst Forecast: $MYGN Given $18.0 Price Target
Myriad Genetics Announces RiskScore Study Published in JCO Precision Oncology
Why Myriad Genetics (MYGN) Stock Is Down Today
Myriad Genetics | 10-Q: Quarterly report
12 Health Care Stocks Moving In Wednesday's Intraday Session
Myriad Genetics Price Target Cut to $8.00/Share From $14.00 by Goldman Sachs
Express News | Goldman Sachs Maintains Buy on Myriad Genetics, Lowers Price Target to $8
Crude Oil Falls 1%; Uber Sales Miss Estimates
Myriad Genetics Down Over 36%, On Track for Largest Percent Decrease Since November 2019 -- Data Talk
Myriad Genetics Analyst Ratings
UBS Adjusts Price Target on Myriad Genetics to $7 From $16, Maintains Neutral Rating
Traders Weigh Tariff News Ahead of Fed Decision, Lifting US Equity Futures Pre-Bell